Samsung Bioepis Marks 14th Anniversary... "Aiming to Be a Respected Company in Society"

Outstanding Employees and Departments Honored
Fundraising and Donations for Children with Rare Diseases

Samsung Bioepis announced on March 2 that it held its 14th anniversary celebration event at its Songdo headquarters in Incheon on February 27.

During the event, the company awarded outstanding employees and departments, and planted an apricot tree to symbolize a new beginning.

Kim Kyunga, President of Samsung Bioepis, is awarding outstanding employees at the 14th anniversary celebration event. Samsung Bioepis

In recognition of "Rare Disease Day" (February 28), the company also carried out community contribution activities in partnership with the non-governmental and non-profit organization Save the Children. These activities included fundraising and sharing of goods for children with rare diseases, donations, assembling first-aid kits, and writing support cards.

Samsung Bioepis currently supplies a total of 11 biosimilar products in Korea across various therapeutic areas, including EPYSQLI, a treatment for rare diseases such as paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and neuromyelitis optica spectrum disorder (NMOSD). Notably, EPYSQLI was launched at about half the price of the original drug (Soliris), significantly improving patient access in Korea.

Kim Kyunga, President of Samsung Bioepis, stated, "Building on the achievements and passion that the company has demonstrated over the past 14 years to improve patients' quality of life with high-quality biopharmaceuticals, we will continue to grow and evolve as a company respected by society."

This content was produced with the assistance of AI translation services.